Lumos Pharma, Inc.
LUMO · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $32,227 | $18,334 | $23,018 | $25,764 |
| - Cash | $13,519 | $16,799 | $23,179 | $35,078 |
| + Debt | $172 | $6,449 | $6,518 | $6,585 |
| Enterprise Value | $18,880 | $7,984 | $6,357 | -$2,729 |
| Revenue | $726 | $488 | $165 | $826 |
| % Growth | 48.8% | 195.8% | -80% | – |
| Gross Profit | $726 | $486 | $163 | $808 |
| % Margin | 100% | 99.6% | 98.8% | 97.8% |
| EBITDA | -$7,640 | -$7,821 | -$10,860 | -$9,986 |
| % Margin | -1,052.3% | -1,602.7% | -6,581.8% | -1,209% |
| Net Income | -$7,467 | -$7,551 | -$10,441 | -$9,457 |
| % Margin | -1,028.5% | -1,547.3% | -6,327.9% | -1,144.9% |
| EPS Diluted | -0.9 | -0.93 | -1.29 | -1.17 |
| % Growth | 3.2% | 27.9% | -10.3% | – |
| Operating Cash Flow | -$5,006 | -$6,380 | -$12,894 | -$7,393 |
| Capital Expenditures | $0 | $0 | $0 | -$13,205 |
| Free Cash Flow | -$5,006 | -$6,380 | -$12,894 | -$20,598 |